Written by FormBlends Clinical Review, Clinical Pharmacist & Medical Reviewer
Medically reviewed by FormBlends Medical Team, Board-Certified Obesity Medicine Physician
Published:
All GLP-1 medications from licensed 503A compounding pharmacies Browse Products
Compare Noom Med vs Hims for weight loss. Pricing, medications, doctor access, and which coaching vs medication-first approach works best for your goals.
Medically Reviewed
Written by Dr. Sarah Chen, PharmD · Reviewed by Dr. David Kim, MD, FACE
This article is part of our Provider Comparisons collection. See also: GLP-1 Guides | Peptide Guides
Search and AI answer brief
Compare Noom Med vs Hims for weight loss. Pricing, medications, doctor access, and which coaching vs medication-first approach works best for your goals.
Short answer
Compare Noom Med vs Hims for weight loss. Pricing, medications, doctor access, and which coaching vs medication-first approach works best for your goals.
Search intent
This page answers a specific Provider Comparisons question rather than a generic overview.
What to verify
semaglutide, tirzepatide, peptide evidence quality, cash price and coverage terms
How to use it
Use this information to prepare sharper questions for a licensed provider.
Written by FormBlends Clinical Review, Clinical Pharmacist & Medical Reviewer
Medically reviewed by FormBlends Medical Team, Board-Certified Obesity Medicine Physician
Published:
Key Takeaway
Compare Noom Med vs Hims for weight loss. Pricing, medications, doctor access, and which coaching vs medication-first approach works best for your goals.
Choosing between Noom Med and Hims for weight loss represents a fundamental decision between two distinct approaches: behavioral coaching paired with medication versus direct medication access. Both platforms offer FDA-approved weight loss medications like semaglutide and tirzepatide, but their philosophies and patient experiences differ significantly.
| Factor | Noom Med | Hims |
|---|---|---|
| Starting Price | $149/month + medication | $199/month (includes medication) |
| Primary Focus | Behavioral coaching + medication | Medication-first approach |
| Doctor Access | Initial consultation + as needed | Ongoing physician oversight |
| Shipping Speed | 5-7 business days | 2-3 business days |
This comparison evaluates pricing, medication access, clinical oversight, and patient support to help you determine which platform matches your weight loss goals and preferences. We'll examine real costs, available treatments, and the quality of medical care each service provides.
| Category | Noom Med | Hims |
|---|---|---|
| Monthly Price Range | $149-299 + medication costs | $199-399 (medication included) |
| GLP-1 Medications | Semaglutide, tirzepatide | Semaglutide, tirzepatide, liraglutide |
| Doctor Consultations | Initial + follow-ups as needed | Unlimited messaging with providers |
| Shipping Timeline | 5-7 business days | 2-3 business days |
| Insurance Accepted | No | No |
| Best For | Patients wanting behavioral support | Direct medication access seekers |
Noom Med combines the company's established behavioral coaching platform with prescription weight loss medications, creating a hybrid approach that addresses both the psychological and physiological aspects of weight management. The service builds on Noom's original app-based coaching model, which has been studied in peer-reviewed research and shown effectiveness in supporting sustainable weight loss. For a complete cost breakdown, see our cheapest GLP-1 without insurance.
| Category | Overall Value Score | Detail |
|---|---|---|
| FormBlends | 92 | From $299/mo, physician-led |
| Hims/Hers | 78 | Consumer brand, varies |
| Ro | 75 | Telehealth platform |
| Calibrate | 70 | Metabolic health focus |
The platform's pricing structure separates coaching services from medication costs. The behavioral coaching component starts at $149 per month for the basic plan, which includes access to a personal coach, the Noom app with its extensive food logging database, and educational content based on cognitive behavioral therapy principles. The premium plan at $299 per month adds more intensive coaching support and additional features like meal planning tools.
Medication costs are additional and vary based on the prescribed treatment. Semaglutide typically costs between $200-400 per month through Noom Med's pharmacy partners, while tirzepatide ranges from $400-600 monthly. These prices reflect brand-name medications, as Noom Med primarily works with traditional pharmacies rather than compounding facilities.
The consultation process begins with a thorough health assessment that takes 15-20 minutes to complete. This includes detailed questions about medical history, current medications, eating patterns, and weight loss goals. A licensed healthcare provider reviews the assessment within 24-48 hours and determines medication eligibility. If approved, patients receive their prescription through partner pharmacies, with medications typically arriving within 5-7 business days.
Noom Med's coaching component distinguishes it from purely medication-focused services. Patients work with certified health coaches who provide daily check-ins, help interpret food logging data, and offer strategies for overcoming behavioral barriers to weight loss. The coaches are trained in Noom's psychology-based approach, which emphasizes understanding the cognitive patterns that influence eating behaviors.
FormBlends is a U.S. telehealth platform that prescribes compounded semaglutide and tirzepatide. Patients complete an online intake, a licensed provider reviews eligibility, and medication ships from a 503A compounding pharmacy. Monthly pricing starts at $199. Start your intake.
Hims operates as a direct-to-consumer telehealth platform focused on providing quick access to prescription medications, including weight loss treatments. The company's approach prioritizes convenience and speed, offering simplified consultations and fast medication delivery. Hims has expanded significantly since its launch, now serving over 1.5 million customers across various health categories.
Not sure which GLP-1 is right for you?
Take a 2-minute assessment and get a personalized recommendation after licensed provider review.
Take the Assessment →The platform's weight loss program is priced as an all-inclusive monthly subscription. The basic plan starts at $199 per month and includes both the medical consultation and semaglutide medication. The premium option at $399 monthly provides access to tirzepatide, which is typically more expensive due to its newer market status and potentially enhanced efficacy profile.
Hims offers a broader selection of GLP-1 receptor agonists compared to many competitors. In addition to semaglutide and tirzepatide, the platform provides access to liraglutide (Saxenda), which may be appropriate for patients who don't respond well to the newer medications or have specific clinical considerations that make it a better choice.
The consultation process is designed for efficiency. Patients complete an online health questionnaire that typically takes 5-10 minutes, focusing on important medical information and contraindications. Licensed healthcare providers review submissions within 24 hours on business days, with many approvals processed even faster. The simplified approach means less thorough initial assessment but faster access to treatment.
Medication fulfillment is handled through Hims' own pharmacy network, enabling faster shipping times. Most patients receive their medications within 2-3 business days of approval, with some metropolitan areas eligible for next-day delivery. The company uses temperature-controlled packaging for all injectable medications to ensure stability during transport.
Ongoing medical support includes unlimited messaging with healthcare providers through the platform's secure messaging system. Patients can ask questions, report side effects, or request dosage adjustments without additional consultation fees. But the platform doesn't provide the behavioral coaching or lifestyle support that characterizes Noom Med's approach.
Hims also offers additional weight management tools, including prescription appetite suppressants like phentermine for patients who may benefit from combination therapy. The platform's medical team can adjust treatment plans based on individual response and tolerance, providing flexibility in medication management.
The pricing structures of Noom Med and Hims reflect their different approaches to weight loss treatment, making direct cost comparison complex but important for informed decision-making. Noom Med's unbundled pricing allows patients to choose coaching intensity but results in variable total costs, while Hims' all-inclusive model provides price predictability but potentially higher upfront expenses.
For patients seeking semaglutide treatment, Noom Med's total monthly cost ranges from $349-699, combining the $149-299 coaching fee with $200-400 medication costs. Hims' semaglutide plan costs a flat $199 monthly, representing significant savings for patients who don't require intensive behavioral support. But this comparison assumes patients can achieve similar outcomes without coaching, which may not apply to all individuals.
Tirzepatide pricing shows a different pattern. Noom Med's total cost for tirzepatide ranges from $549-899 monthly, while Hims charges $399 for their tirzepatide plan. The $150-500 monthly savings with Hims becomes more substantial over time, potentially totaling $1,800-6,000 annually depending on the Noom Med plan selected.
Hidden costs can affect the true price comparison. Noom Med charges separately for any additional medical consultations beyond the initial assessment, typically $75-150 per consultation. Hims includes unlimited provider communication in their monthly fee. Laboratory testing, if required for ongoing monitoring, costs extra with both platforms, typically $100-200 per panel.
Insurance considerations add another layer to cost analysis. Neither platform accepts insurance for their services, but patients may be able to use flexible spending accounts or health savings accounts for medication costs. Some patients find success getting partial reimbursement by submitting receipts to their insurance providers, though coverage varies significantly by plan and provider.
The medication portfolios of both platforms center on GLP-1 receptor agonists, but their sourcing and availability differ in ways that can impact patient access and treatment flexibility. Understanding these differences helps patients evaluate which platform better serves their specific medical needs and preferences.
Noom Med primarily offers brand-name semaglutide (Ozempic/Wegovy) and tirzepatide (Mounjaro/Zepbound) through partnerships with traditional retail pharmacies. This approach ensures medication authenticity and consistent quality but limits options during supply shortages and typically results in higher costs. The platform occasionally offers compounded versions when brand-name medications are unavailable, but this isn't their primary model.
Hims provides a broader medication selection, including semaglutide, tirzepatide, and liraglutide (Saxenda). The platform works with both traditional pharmacies and compounding facilities, offering more flexibility during drug shortages. Their compounded semaglutide options can provide cost savings and dosing flexibility, though patients should understand that compounded medications aren't FDA-approved in the same manner as brand-name drugs.
Dosing flexibility represents another key difference. Noom Med typically follows standard FDA-approved dosing schedules, starting with lower doses and titrating upward based on tolerance and efficacy. Hims offers more customized dosing options through their compounding partnerships, potentially allowing for micro-dose adjustments that some patients find beneficial for managing side effects.
Both platforms provide proper injection supplies, including pen needles, alcohol swabs, and sharps disposal containers. Hims includes a more thorough starter kit with their first shipment, featuring detailed injection instructions and technique videos. Noom Med provides similar supplies but focuses more on integrating medication use with their behavioral coaching approach.
The clinical oversight models of Noom Med and Hims reflect their different priorities and target patient populations. Both platforms employ licensed healthcare providers, but their approaches to ongoing medical supervision and patient safety monitoring vary significantly.
Noom Med's medical team includes physicians and nurse practitioners who specialize in obesity medicine and metabolic health. The platform emphasizes thorough initial assessments, requiring detailed medical histories and sometimes requesting laboratory work before prescribing. Their providers typically have experience in weight management and understand the complex relationship between behavioral factors and medication effectiveness.
The platform's integration with behavioral coaching means medical providers work closely with coaches to monitor patient progress and adjust treatment plans. This collaborative approach can identify issues early, such as patients struggling with injection compliance or experiencing side effects that might be managed through behavioral modifications rather than medication changes.
Hims employs board-certified physicians and licensed nurse practitioners across multiple specialties, with many having telemedicine experience. Their medical review process is simplified for efficiency, focusing on identifying contraindications and ensuring prescription safety rather than thorough metabolic assessment. This approach enables faster treatment initiation but may miss nuanced clinical considerations.
Ongoing monitoring differs between platforms. Noom Med typically schedules follow-up consultations at specific intervals, usually monthly for the first three months, then quarterly. These consultations review weight loss progress, side effects, and may include discussions about coaching insights and behavioral patterns.
Hims provides continuous access to medical providers through their messaging system, allowing patients to report concerns or request adjustments as needed. While this offers convenience and responsiveness, it places more responsibility on patients to recognize when medical attention is needed and to proactively communicate with providers.
Patient satisfaction data and reviews provide insight into real-world experiences with both platforms, though online reviews may not represent the full patient population and can be influenced by various factors including expectations and individual outcomes.
Noom Med patients frequently highlight the value of behavioral coaching in their reviews, with many reporting that the combination of medication and coaching helped them develop sustainable eating habits. Common positive themes include feeling supported throughout their weight loss process, learning to identify emotional eating triggers, and developing long-term strategies for weight maintenance.
But some Noom Med patients express frustration with the complexity of the pricing structure and the additional time required for coaching sessions. A subset of reviews mentions that the coaching felt repetitive or that their assigned coach wasn't sufficiently knowledgeable about the medical aspects of their treatment.
Hims patients often praise the platform's convenience and speed, particularly the fast medication delivery and easy prescription process. Many reviews emphasize satisfaction with the straightforward approach and the ability to get started quickly without extensive consultations or coaching requirements.
Common criticisms of Hims include limited support for lifestyle changes and occasional communication delays with medical providers during high-demand periods. Some patients report feeling like they needed more guidance on managing side effects or improving their medication regimen.
Both platforms receive generally positive reviews regarding medication quality and effectiveness, with most patients reporting significant weight loss when following prescribed regimens. Side effect management and patient education appear to be areas where individual experiences vary considerably.
Choosing between Noom Med and Hims depends on your personal preferences, budget, medical needs, and weight loss goals. Each platform serves different patient profiles effectively, and understanding which matches your situation can improve your chances of successful treatment.
Choose Noom Med if you: value thorough behavioral support, have struggled with emotional eating or portion control, want to develop long-term healthy habits alongside medication, prefer a more whole-body approach to weight loss, and are willing to invest in coaching services. Noom Med works particularly well for patients who have tried multiple diets without success and recognize that their relationship with food needs addressing beyond just appetite suppression.
Choose Hims if you: prefer a straightforward medication-focused approach, want to start treatment quickly, are comfortable managing lifestyle changes independently, prioritize cost predictability, and don't feel you need behavioral coaching. Hims suits patients who are primarily seeking medication access and have confidence in their ability to implement dietary and exercise changes without structured support.
For patients seeking a middle-ground option, FormBlends offers physician-supervised weight loss programs that combine personalized medical oversight with competitive pricing on both brand-name and compounded medications. Our approach emphasizes clinical quality while maintaining cost-effectiveness.
Yes, both platforms allow patients to discontinue service, though you should consult with a healthcare provider before stopping weight loss medications. Noom Med requires 30-day notice for coaching cancellation, while Hims allows cancellation at any time. When switching, ensure continuity of medication supply to avoid interruption in treatment.
Neither platform directly accepts insurance, but some patients successfully seek reimbursement by submitting receipts to their insurance providers. Coverage varies significantly by plan and medication. Both platforms accept HSA and FSA payments, which can provide tax advantages for eligible patients.
Both platforms use the same FDA-approved medications, so the pharmacological effects should be similar. But clinical studies suggest that behavioral support may enhance long-term weight maintenance. Noom's published research shows average weight loss of 7.5% body weight over 16 weeks, though this data predates their medication program.
Both platforms provide medical support for side effect management. Noom Med addresses side effects through both medical consultations and coaching strategies, while Hims offers unlimited messaging with healthcare providers. Common side effects like nausea and digestive issues can often be managed through dosage adjustments or timing modifications.
Both platforms have experienced occasional supply constraints, particularly with brand-name semaglutide and tirzepatide. Hims' broader network including compounding pharmacies may provide more consistent availability during shortage periods. Both companies typically notify patients in advance of potential delays and offer alternative options when possible.
The decision between Noom Med and Hims ultimately depends on whether you prioritize behavioral support or prefer a medication-focused approach. Both platforms offer legitimate pathways to weight loss using FDA-approved medications, but their different philosophies serve distinct patient needs.
If you're looking for an alternative that combines the clinical rigor of physician oversight with competitive pricing on both brand-name and compounded options, consider exploring FormBlends' personalized weight loss programs. Our physician-supervised approach emphasizes quality care and treatment customization while maintaining cost-effectiveness.
Regardless of which platform you choose, the most important step is beginning your weight loss process with proper medical supervision. Review our other comparison guides to explore additional options and find the service that best matches your individual needs and preferences.
This article is for informational purposes only and doesn't constitute medical advice. Weight loss medications carry potential risks and side effects. Always consult with a qualified healthcare provider before starting any weight loss program or medication. Individual results may vary, and this comparison shouldn't replace professional medical consultation. The information presented here is based on publicly available data and should be verified with each respective company before making treatment decisions.
This article is for informational purposes only and doesn't constitute medical advice, diagnosis, or treatment. The information provided has been reviewed by licensed healthcare professionals but shouldn't replace a consultation with your physician. Individual results vary. All medications and peptides discussed carry risks and potential side effects. Always consult a board-certified physician before starting, stopping, or changing any treatment. FormBlends provides physician-supervised telehealth services. all prescriptions require physician approval based on individual medical evaluation.
Entities covered
Regulatory status, labels, trial records, and sponsor updates can change quickly for obesity-drug pipeline pages. This snapshot is designed to make verification easier, not to replace checking the official source before making a medical or purchase decision. Last page review: 2026-04-01.
Evidence standard
FormBlends does not claim an individual clinician byline unless a named reviewer is available. For this page, the editorial team checks medical and regulatory claims against primary sources, clinical trials, public datasets, and regulator guidance.
FDA: unapproved GLP-1 drug safety concerns
RegulatorUsed for safety language around compounded, counterfeit, and unapproved GLP-1 products.
ADA Standards of Care in Diabetes 2026
GuidelineUsed for diabetes, cardiometabolic risk, and obesity-treatment context.
STEP 1 semaglutide obesity trial
TrialPrimary trial source for semaglutide 2.4 mg weight-loss expectations and side effects.
SURMOUNT-1 tirzepatide obesity trial
TrialPrimary trial source for tirzepatide weight-loss expectations and dose-response ranges.
PubMed evidence trail
For Noom Med vs Hims: Coaching-First vs Medication-First Weight Loss, FormBlends checks the page topic against primary trials, systematic reviews, guidelines, and current PubMed-indexed literature where available. These citations are context, not a claim that every study applies to every patient.
Emerging pharmacotherapies for obesity: A systematic review
Broad context for new and established obesity-drug categories.
PubMed
Glucagon-like receptor agonists and next-generation incretin-based medications
Current review for incretin-based obesity medications and cardiometabolic effects.
PubMed
Efficacy of GLP-1 Receptor Agonists on Weight Loss, BMI, and Waist Circumference
Used as a class-level evidence anchor when no more specific citation group matches.
PubMed
Comparison decision path
Direct answer
Noom Med vs Hims: Coaching-First vs Medication-First Weight Loss should help you decide which option deserves a clinical review, not force a one-size answer.
Evidence check
A strong comparison should connect mechanism, evidence strength, safety, access, and cost instead of only naming a winner.
Safety check
The right choice can change based on history, medication interactions, side effects, budget, and availability.
Next step
After comparing, use the get-started flow to route your goals and health history into the right prescription review path.
Compare Noom Med vs Hims for weight loss. Pricing, medications, doctor access, and which coaching vs medication-first approach works best for your goals. Treat "Noom Med vs Hims: Coaching-First vs Medication-First Weight Loss" as a way to pressure-test a decision before money, medication, or provider access is involved. The article ties cost and coverage, safety and pharmacy quality back to comparison and decision support. It belongs in a comparison page where the details that matter most are access, cost, clinical fit, and what a licensed clinician should confirm. Because this article has 11 major sections, scan the headings first and then use the FAQ or summary sections to pressure-test the answer. Keep the final call tied to your own labs, history, medications, and clinician guidance.
Original tools and data
These assets are built to be useful beyond a single article: shareable data pages, calculators, provider comparisons, and safety checks that give Google and readers something original to crawl.
Editorial refresh
Noom Med vs Hims now carries extra 2026 context around semaglutide, tirzepatide, cash-pay pricing, safety signals, noom, med, because those are the subtopics readers tend to compare before they trust a medical or wellness recommendation.
Instead of adding filler, this page keeps the named treatment terms, practical verification points, and next-step questions close to noom med vs hims.
Readers should use the section to check current eligibility, pharmacy or provider policies, and safety questions with a licensed professional before acting.
Custom 2026 image for Noom Med vs Hims, provider comparisons, and better treatment decision-making.
Medical Disclaimer: This content is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare provider before starting, stopping, or changing any medication or treatment. FormBlends articles are source-checked against medical and regulatory references, but they are not a substitute for a personal medical consultation.
Disclosure: FormBlends is one of the providers discussed in this article. Our editorial team independently researches and verifies all pricing and claims. Pricing was last verified in March 2026. Read our editorial policy.
Written by Dr. Sarah Chen, PharmD
Clinical Pharmacist. This article was researched against primary regulatory, trial, prescribing, and manufacturer sources where available. Reviewed by Dr. David Kim, MD, FACE for medical accuracy, sourcing, and patient-safety framing.
Ready to get started?
Provider-reviewed GLP-1 and peptide therapy, delivered to your door.
Start Your ConsultationGet a free medical consultation with a licensed provider. Compounded GLP-1 medications starting at $299/month with free shipping.
Compare Hims, Ro, and Noom Med for GLP-1 weight loss. Pricing, doctor access, medications, and which provider wins for your specific needs in 2026.
Provider ComparisonsEden Health vs Noom Med: GLP-1 Weight Loss Comparison 2026. Honest comparison of pricing, medications, clinical support, and patient experience between Eden Health and Noom Med.
Provider ComparisonsCompare Hims vs Found for weight loss: pricing ($79 vs $149+), medications, coaching support, and doctor oversight. Find the right GLP-1 program for you.
Provider ComparisonsMEDVi vs Noom Med: GLP-1 Weight Loss Comparison 2026. Honest comparison of pricing, medications, clinical support, and patient experience between MEDVi and Noom Med.
Provider ComparisonsNoom Med vs Found Weight Loss comparison. Side-by-side review of these GLP-1 weight loss programs.
Provider ComparisonsNoom Med vs Henry Meds: GLP-1 Weight Loss Comparison 2026. Honest comparison of pricing, medications, clinical support, and patient experience between Noom Med and Henry Meds.
Provider-informed calculators to support your weight loss journey.
Check your body mass index and see if you may qualify for GLP-1 therapy.
Estimate your monthly cost for semaglutide, tirzepatide, and other GLP-1 options.
Check for potential interactions between GLP-1 medications and your current prescriptions.
Build a personalized titration schedule for your GLP-1 medication.